Michael Clayman

Michael Clayman

Chairman at
Anokion SA
74 year
Health Technology
Consumer Services
Industrial Services

Profile

Michael D.
Clayman
is the founder of Flexion Therapeutics, Inc., which was founded in 2007.
He held the title of President, Chief Executive Officer & Director from 2018 to 2021.
Currently, he is the Non-Executive Chairman at Anokion SA since 2016, Chairman at Ribometrix, Inc. since 2019, Chairman at Nido Biosciences, Inc. since 2022, and Director at Kanyos Bio, Inc. He previously worked as an Independent Director at Akebia Therapeutics, Inc. from 2014 to 2018.
He also held positions at Eli Lilly & Co., Abbott Cardiovascular Systems, Inc., Chorus Group Ltd., Lilly Research Laboratories, and Perelman School of Medicine.
He completed his undergraduate degree at Yale University and obtained a doctorate from UC San Diego School of Medicine.

Michael Clayman active positions

CompaniesPositionStart
Chairman 14/06/2018
Director/Board Member -
Chairman 27/09/2019
Chairman 01/08/2022

Former positions of Michael Clayman

CompaniesPositionEnd
FLEXION THERAPEUTICS, INC. Chief Executive Officer 19/11/2021
AKEBIA THERAPEUTICS, INC. Director/Board Member 12/12/2018
Corporate Officer/Principal 01/01/2007
General Counsel -
ELI LILLY AND COMPANY Corporate Officer/Principal -
See the detail of Michael Clayman's experience

Training of Michael Clayman

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

67

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies13

Health Technology

Health Technology

Health Technology

Industrial Services

Consumer Services

Commercial Services

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Michael Clayman
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!